Skip to content

Analysis of clinical rational use of vancomycin in inpatients

Analysis of clinical rational use of vancomycin in inpatients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098471
Enrollment
Unknown
Registered
2025-03-10
Start date
2024-11-04
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious disease

Interventions

Observation group:None

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients admitted to our hospital during the 2022-2024 period; 2.Vancomycin was used during hospitalization; 3.Complete medical records, including diagnostic information, medication records, test results, etc;

Exclusion criteria

Exclusion criteria: 1.Patients whose medical records are severely missing and cannot be analyzed effectively; 2.Patients who dropped out of treatment or were transferred to hospitals for various reasons; 3.Death occurred during hospitalization;

Design outcomes

Primary

MeasureTime frame
indication;Dose and course;Curative effect evaluation;

Secondary

MeasureTime frame
Adverse reaction;Microorganism inspection status;Drug combination;Drug utilization index of vancomycin;

Countries

China

Contacts

Public ContactTian Pei

Beijing Bo'ai Hospital

tianpei0024@163.com+86 10 87567006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026